A Unique Candidate

Researchers in Massachusetts are testing a unique coronavirus vaccine candidate that uses an established type of gene therapy to trigger an immune response that could stave off the virus,

The vaccine project is the only one that attempts to use a small dose of a harmless “adeno-associated virus” to deliver DNA into a patient’s cells that could trigger an immune response.

One major advantage: Industry experience in producing AAV-based medications, including 2 drugs that have been approved by the FDA.

The Boston Herald

Secondary Topic
Comments +

0 comments

Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top